Tapewire

Nasdaq · USD

COYA

Coya Therapeutics, Inc.

Export transactions ↓
Tapewire entity
6727
SEC CIK
0001835022
Parsed reports
68

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 09, 2026 Filed Apr 9, 2026 22:49 UTC
Pavao Mark HDirector
GrantStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $4.53 $0.00
Disclosure

SEC source: 0001193125-26-149968 · ownership.xml · derivative · entry 1

Pavao Mark H · CIK 0001297988 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock, par value $0.0001 per share · 10,000 shares

Expires 2036-04-09

F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.

Read SEC document
January 22, 2026 Filed Jan 26, 2026 08:00 UTC
Swaminathan ArunDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 293,983 $0.00 Strike: $4.73 $0.00
Disclosure

SEC source: 0001193125-26-021724 · ownership.xml · derivative · entry 1

Swaminathan Arun · CIK 0002034346 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 293,983

Underlying: Common Stock, par value $0.0001 per share · 293,983 shares

Expires 2036-01-22

F1 · derivative.exercise_date: Subject to continuous service through each vesting date, the shares underlying the option will vest in monthly installments over the next 36 months. Upon a change in control of the Issuer, the shares underlying the option will vest and the option will become immediately exercisable pursuant to the Issuer's 2021 Equity Incentive Plan, as amended and restated effective November 17, 2022.

Read SEC document
January 22, 2026 Filed Jan 26, 2026 08:00 UTC
SNYDER DAVID SChief Financial Officer
GrantStock Option (right to buy) · Derivative 140,041 $0.00 Strike: $4.73 $0.00
Disclosure

SEC source: 0001193125-26-021729 · ownership.xml · derivative · entry 1

SNYDER DAVID S · CIK 0001398625 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,041

Underlying: Common Stock, par value $0.0001 per share · 140,041 shares

Expires 2036-01-22

F1 · derivative.exercise_date: Subject to continuous service through each vesting date, the shares underlying the option will vest in monthly installments over the next 36 months. Upon a change in control of the Issuer, the shares underlying the option will vest and the option will become immediately exercisable pursuant to the Issuer's 2021 Equity Incentive Plan, as amended and restated effective November 17, 2022.

Read SEC document
January 22, 2026 Filed Jan 26, 2026 13:00 UTC
Grossman FredChief Medical Officer
GrantStock Option (right to buy) · Derivative 140,041 $0.00 Strike: $4.73 $0.00
Disclosure

SEC source: 0001193125-26-021728 · ownership.xml · derivative · entry 1

Grossman Fred · CIK 0001985154 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,041

Underlying: Common Stock, par value $0.0001 per share · 140,041 shares

Expires 2036-01-22

F1 · derivative.exercise_date: Subject to continuous service through each vesting date, the shares underlying the option will vest in monthly installments over the next 36 months. Upon a change in control of the Issuer, the shares underlying the option will vest and the option will become immediately exercisable pursuant to the Issuer's 2021 Equity Incentive Plan, as amended and restated effective November 17, 2022.

Read SEC document
January 22, 2026 Filed Jan 26, 2026 13:00 UTC
Berman HowardDirector · Executive Chairman
GrantStock Option (right to buy) · Derivative 15,257 $0.00 Strike: $4.73 $0.00
Disclosure

SEC source: 0001193125-26-021725 · ownership.xml · derivative · entry 1

Berman Howard · CIK 0001952986 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,257

Underlying: Common Stock, par value $0.0001 per share · 15,257 shares

Expires 2036-01-22

F1 · derivative.exercise_date: Subject to continuous service through each vesting date, the shares underlying the option will vest in monthly installments over the next 36 months. Upon a change in control of the Issuer, the shares underlying the option will vest and the option will become immediately exercisable pursuant to the Issuer's 2021 Equity Incentive Plan, as amended and restated effective November 17, 2022.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 00:27 UTC GrantStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $5.65 $0.00
Disclosure

SEC source: 0001193125-26-005023 · ownership.xml · derivative · entry 1

GOLDSTEIN DOV A MD · CIK 0001120478 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock, par value $0.0001 per share · 10,000 shares

Expires 2036-01-02

F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 19:25 UTC GrantStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $5.65 $0.00
Disclosure

SEC source: 0001193125-26-005018 · ownership.xml · derivative · entry 1

ROSS WILBUR L JR · CIK 0001026610 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock, par value $0.0001 per share · 10,000 shares

Expires 2036-01-02

F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 00:26 UTC GrantStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $5.65 $0.00
Disclosure

SEC source: 0001193125-26-005022 · ownership.xml · derivative · entry 1

Weinand Dieter · CIK 0001744419 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock, par value $0.0001 per share · 10,000 shares

Expires 2036-01-02

F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 00:27 UTC GrantStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $5.65 $0.00
Disclosure

SEC source: 0001193125-26-005024 · ownership.xml · derivative · entry 1

Villalobos Anabella · CIK 0001952966 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock, par value $0.0001 per share · 10,000 shares

Expires 2036-01-02

F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.

Read SEC document
January 02, 2026 Filed Jan 7, 2026 00:21 UTC
Lee AnnDirector
GrantStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $5.65 $0.00
Disclosure

SEC source: 0001193125-26-005015 · ownership.xml · derivative · entry 1

Lee Ann · CIK 0001953080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock, par value $0.0001 per share · 10,000 shares

Expires 2036-01-02

F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.

Read SEC document
August 18, 2025 Filed Aug 19, 2025 20:01 UTC Exercise / conversionStock Option (right to buy) · Derivative 17,557 $0.00 Strike: $1.09 $0.00
Disclosure

SEC source: 0001641172-25-024820 · ownership.xml · derivative · entry 2

GOLDSTEIN DOV A MD · CIK 0001120478 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,557 shares

Expires 2031-03-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This option is fully vested.

Read SEC document
August 18, 2025 Filed Aug 19, 2025 20:01 UTC Exercise / conversionCommon Stock, par value $0.0001 per share 17,557 $1.09 $19,137.13
Disclosure

SEC source: 0001641172-25-024820 · ownership.xml · nonDerivative · entry 1

GOLDSTEIN DOV A MD · CIK 0001120478 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,557

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 25, 2025 Filed Feb 26, 2025 02:30 UTC GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $5.97 $0.00
Disclosure

SEC source: 0000950170-25-027253 · ownership.xml · derivative · entry 1

GOLDSTEIN DOV A MD · CIK 0001120478 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock, par value $0.0001 per share · 5,000 shares

Expires 2035-02-25

F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.

Read SEC document
February 25, 2025 Filed Feb 25, 2025 21:30 UTC GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $5.97 $0.00
Disclosure

SEC source: 0000950170-25-027251 · ownership.xml · derivative · entry 1

ROSS WILBUR L JR · CIK 0001026610 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock, par value $0.0001 per share · 5,000 shares

Expires 2035-02-25

F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.

Read SEC document
February 25, 2025 Filed Feb 26, 2025 02:30 UTC GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $5.97 $0.00
Disclosure

SEC source: 0000950170-25-027252 · ownership.xml · derivative · entry 1

Weinand Dieter · CIK 0001744419 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock, par value $0.0001 per share · 5,000 shares

Expires 2035-02-25

F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.

Read SEC document
February 25, 2025 Filed Feb 26, 2025 02:30 UTC
Lee AnnDirector
GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $5.97 $0.00
Disclosure

SEC source: 0000950170-25-027255 · ownership.xml · derivative · entry 1

Lee Ann · CIK 0001953080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock, par value $0.0001 per share · 5,000 shares

Expires 2035-02-25

F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.

Read SEC document
February 25, 2025 Filed Feb 26, 2025 02:30 UTC GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $5.97 $0.00
Disclosure

SEC source: 0000950170-25-027254 · ownership.xml · derivative · entry 1

Villalobos Anabella · CIK 0001952966 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock, par value $0.0001 per share · 5,000 shares

Expires 2035-02-25

F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.

Read SEC document
January 09, 2025 Filed Jan 13, 2025 08:00 UTC
Swaminathan ArunDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 240,964 $0.00 Strike: $6.07 $0.00
Disclosure

SEC source: 0000950170-25-004573 · ownership.xml · derivative · entry 1

Swaminathan Arun · CIK 0002034346 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 240,964

Underlying: Common Stock, par value $0.0001 per share · 240,964 shares

Expires 2035-01-09

F1 · derivative.exercise_date: The option will vest in monthly installments over 36 months commencing on February 9, 2025, subject to continuous service on each vesting date.

Read SEC document
January 09, 2025 Filed Jan 13, 2025 08:00 UTC
SNYDER DAVID SChief Financial Officer
GrantStock Option (right to buy) · Derivative 140,562 $0.00 Strike: $6.07 $0.00
Disclosure

SEC source: 0000950170-25-004575 · ownership.xml · derivative · entry 1

SNYDER DAVID S · CIK 0001398625 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,562

Underlying: Common Stock, par value $0.0001 per share · 140,562 shares

Expires 2035-01-09

F1 · derivative.exercise_date: The option will vest in monthly installments over 36 months commencing on February 9, 2025, subject to continuous service on each vesting date.

Read SEC document
January 09, 2025 Filed Jan 13, 2025 13:00 UTC
Grossman FredChief Medical Officer
GrantStock Option (right to buy) · Derivative 140,562 $0.00 Strike: $6.07 $0.00
Disclosure

SEC source: 0000950170-25-004572 · ownership.xml · derivative · entry 1

Grossman Fred · CIK 0001985154 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,562

Underlying: Common Stock, par value $0.0001 per share · 140,562 shares

Expires 2035-01-09

F1 · derivative.exercise_date: The option will vest in monthly installments over 36 months commencing on February 9, 2025, subject to continuous service on each vesting date.

Read SEC document
January 09, 2025 Filed Jan 13, 2025 13:00 UTC GrantStock Option (right to buy) · Derivative 150,602 $0.00 Strike: $6.07 $0.00
Disclosure

SEC source: 0000950170-25-004571 · ownership.xml · derivative · entry 1

Berman Howard · CIK 0001952986 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,602

Underlying: Common Stock, par value $0.0001 per share · 150,602 shares

Expires 2035-01-09

F1 · derivative.exercise_date: The option will vest in monthly installments over 36 months commencing on February 9, 2025, subject to continuous service on each vesting date.

Read SEC document
January 01, 2025 Filed Jan 4, 2025 02:31 UTC GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $5.73 $0.00
Disclosure

SEC source: 0000950170-25-001571 · ownership.xml · derivative · entry 1

GOLDSTEIN DOV A MD · CIK 0001120478 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock, par value $0.0001 per share · 5,000 shares

Expires 2035-01-01

F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.

Read SEC document
January 01, 2025 Filed Jan 3, 2025 21:30 UTC GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $5.73 $0.00
Disclosure

SEC source: 0000950170-25-001570 · ownership.xml · derivative · entry 1

ROSS WILBUR L JR · CIK 0001026610 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock, par value $0.0001 per share · 5,000 shares

Expires 2035-01-01

F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.

Read SEC document
January 01, 2025 Filed Jan 4, 2025 02:30 UTC GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $5.73 $0.00
Disclosure

SEC source: 0000950170-25-001567 · ownership.xml · derivative · entry 1

Weinand Dieter · CIK 0001744419 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock, par value $0.0001 per share · 5,000 shares

Expires 2035-01-01

F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.

Read SEC document
January 01, 2025 Filed Jan 4, 2025 02:30 UTC
Lee AnnDirector
GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $5.73 $0.00
Disclosure

SEC source: 0000950170-25-001569 · ownership.xml · derivative · entry 1

Lee Ann · CIK 0001953080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock, par value $0.0001 per share · 5,000 shares

Expires 2035-01-01

F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.

Read SEC document
January 01, 2025 Filed Jan 4, 2025 02:30 UTC GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $5.73 $0.00
Disclosure

SEC source: 0000950170-25-001568 · ownership.xml · derivative · entry 1

Villalobos Anabella · CIK 0001952966 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock, par value $0.0001 per share · 5,000 shares

Expires 2035-01-01

F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.

Read SEC document
November 14, 2024 Filed Nov 14, 2024 18:08 UTC
SNYDER DAVID SChief Financial Officer
PurchaseCommon Stock, par value $0.0001 per share 1,800 $7.19 $12,934.44
Disclosure

SEC source: 0001493152-24-046106 · ownership.xml · nonDerivative · entry 1

SNYDER DAVID S · CIK 0001398625 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,800

Read SEC document
November 13, 2024 Filed Nov 13, 2024 16:05 UTC
Swaminathan ArunDirector · Chief Executive Officer
PurchaseCommon Stock, par value $0.0001 per share 5,000 $7.36 $36,797.00
Disclosure

SEC source: 0001493152-24-045120 · ownership.xml · nonDerivative · entry 1

Swaminathan Arun · CIK 0002034346 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Read SEC document
November 11, 2024 Filed Nov 12, 2024 16:58 UTC
Swaminathan ArunDirector · Chief Executive Officer
PurchaseCommon Stock, par value $0.0001 per share 5,000 $7.34 $36,689.00
Disclosure

SEC source: 0001493152-24-044819 · ownership.xml · nonDerivative · entry 1

Swaminathan Arun · CIK 0002034346 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Read SEC document
November 11, 2024 Filed Nov 12, 2024 23:03 UTC
Grossman FredChief Medical Officer
PurchaseCommon Stock, par value $0.0001 per share 2,710 $7.37 $19,972.70
Disclosure

SEC source: 0001493152-24-044896 · ownership.xml · nonDerivative · entry 1

Grossman Fred · CIK 0001985154 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,710

Read SEC document
June 03, 2024 Filed Jun 5, 2024 20:00 UTC
SNYDER DAVID SChief Financial Officer
GrantStock Option (right to buy) · Derivative 70,596 $0.00 Strike: $8.15 $0.00
Disclosure

SEC source: 0000950170-24-069551 · ownership.xml · derivative · entry 1

SNYDER DAVID S · CIK 0001398625 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,596

Underlying: Common Stock · 70,596 shares

Expires 2034-06-03

F1 · derivative.exercise_date: Subject to continuous service, the shares subject to the option vest in equal monthly installments over a period of 36 months, commencing on July 3, 2024.

Read SEC document
June 03, 2024 Filed Jun 6, 2024 00:00 UTC
Berman HowardDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 163,663 $0.00 Strike: $8.15 $0.00
Disclosure

SEC source: 0000950170-24-069550 · ownership.xml · derivative · entry 1

Berman Howard · CIK 0001952986 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 163,663

Underlying: Common Stock · 163,663 shares

Expires 2034-06-03

F1 · derivative.exercise_date: Subject to continuous service, the shares subject to the option vest in equal monthly installments over a period of 36 months, commencing on July 3, 2024.

Read SEC document
June 03, 2024 Filed Jun 6, 2024 00:00 UTC
Grossman FredChief Medical Officer
GrantStock Option (right to buy) · Derivative 70,596 $0.00 Strike: $8.15 $0.00
Disclosure

SEC source: 0000950170-24-069549 · ownership.xml · derivative · entry 1

Grossman Fred · CIK 0001985154 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,596

Underlying: Common Stock · 70,596 shares

Expires 2034-06-03

F1 · derivative.exercise_date: Subject to continuous service, the shares subject to the option vest in equal monthly installments over a period of 36 months, commencing on July 3, 2024.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 20:00 UTC
SNYDER DAVID SChief Financial Officer
GrantStock Option (right to buy) · Derivative 81,819 $0.00 Strike: $5.90 $0.00
Disclosure

SEC source: 0001493152-24-004815 · ownership.xml · derivative · entry 1

SNYDER DAVID S · CIK 0001398625 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,819

Underlying: Common Stock · 81,819 shares

Expires 2034-01-31

F1 · derivative.exercise_date: The option will vest in 36 equal monthly installments commencing February 29, 2024, subject to continuous service on each vesting date.

Read SEC document
January 31, 2024 Filed Feb 3, 2024 01:00 UTC
Grossman FredChief Medical Officer
GrantStock Option (right to buy) · Derivative 74,069 $0.00 Strike: $5.90 $0.00
Disclosure

SEC source: 0001493152-24-004813 · ownership.xml · derivative · entry 2

Grossman Fred · CIK 0001985154 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,069

Underlying: Common Stock, par value $0.0001 per share · 74,069 shares

Expires 2034-01-31

F2 · derivative.exercise_date: The option will vest as to 24,689 shares on July 11, 2024, with the remaining shares vesting in 24 equal monthly installments.

Read SEC document
January 31, 2024 Filed Feb 3, 2024 01:00 UTC
Grossman FredChief Medical Officer
GrantStock Option (right to buy) · Derivative 81,819 $0.00 Strike: $5.90 $0.00
Disclosure

SEC source: 0001493152-24-004813 · ownership.xml · derivative · entry 1

Grossman Fred · CIK 0001985154 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,819

Underlying: Common Stock, par value $0.0001 per share · 81,819 shares

Expires 2034-01-31

F1 · derivative.exercise_date: The option will vest in 36 equal monthly installments commencing February 29, 2024, subject to continuous service on each vesting date.

Read SEC document
January 31, 2024 Filed Feb 3, 2024 01:00 UTC
Berman HowardDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 189,680 $0.00 Strike: $5.90 $0.00
Disclosure

SEC source: 0001493152-24-004814 · ownership.xml · derivative · entry 1

Berman Howard · CIK 0001952986 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 189,680

Underlying: Common Stock, par value $0.0001 per share · 189,680 shares

Expires 2034-01-31

F1 · derivative.exercise_date: The option will vest in 36 equal monthly installments commencing February 29, 2024, subject to continuous service on each vesting date.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 16:05 UTC GrantStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $6.97 $0.00
Disclosure

SEC source: 0001493152-24-001080 · ownership.xml · derivative · entry 1

ROSS WILBUR L JR · CIK 0001026610 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock, par value $0.0001 per share · 10,000 shares

Expires 2034-01-02

F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of appointment.

Read SEC document
January 01, 2024 Filed Jan 19, 2024 23:30 UTC GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $7.41 $0.00
Disclosure

SEC source: 0001493152-24-003110 · ownership.xml · derivative · entry 1

GOLDSTEIN DOV A MD · CIK 0001120478 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock, par value $0.0001 per share · 5,000 shares

Expires 2034-01-01

F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.

Read SEC document
January 01, 2024 Filed Jan 19, 2024 18:30 UTC GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $7.41 $0.00
Disclosure

SEC source: 0001493152-24-003111 · ownership.xml · derivative · entry 1

Garren Hideki · CIK 0001854126 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock, par value $0.0001 per share · 5,000 shares

Expires 2034-01-01

F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.

Read SEC document
January 01, 2024 Filed Jan 19, 2024 23:30 UTC GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $7.41 $0.00
Disclosure

SEC source: 0001493152-24-003109 · ownership.xml · derivative · entry 1

Weinand Dieter · CIK 0001744419 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock, par value $0.0001 per share · 5,000 shares

Expires 2034-01-01

F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.

Read SEC document
January 01, 2024 Filed Jan 19, 2024 23:30 UTC
Lee AnnDirector
GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $7.41 $0.00
Disclosure

SEC source: 0001493152-24-003108 · ownership.xml · derivative · entry 1

Lee Ann · CIK 0001953080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock, par value $0.0001 per share · 5,000 shares

Expires 2034-01-01

F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.

Read SEC document
January 01, 2024 Filed Jan 19, 2024 23:30 UTC GrantStock Option (right to buy) · Derivative 5,000 $0.00 Strike: $7.41 $0.00
Disclosure

SEC source: 0001493152-24-003107 · ownership.xml · derivative · entry 1

Villalobos Anabella · CIK 0001952966 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock, par value $0.0001 per share · 5,000 shares

Expires 2034-01-01

F1 · derivative.exercise_date: Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant.

Read SEC document
August 22, 2023 Filed Mar 6, 2024 01:00 UTC
Lee AnnDirector
PurchaseCommon Stock, par value $0.0001 per share 1,000 $3.62 $3,620.00
Disclosure

SEC source: 0001493152-24-008916 · ownership.xml · nonDerivative · entry 1

Lee Ann · CIK 0001953080 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse IRA

Disclosed balance after: 17,479

F1 · price: Represents the weighted average purchase price. The actual purchase prices range from $3.59 to $3.63 per share. The Reporting Person will supply the SEC, the Issuer, or a security holder of the Issuer, with full information regarding the number of shares at each price upon request.

Read SEC document
August 18, 2023 Filed Aug 22, 2023 00:15 UTC GrantStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $3.43 $0.00
Disclosure

SEC source: 0000899243-23-018335 · doc4.xml · derivative · entry 1

Weinand Dieter · CIK 0001744419 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock, par value $0.0001 per share · 10,000 shares

Expires 2033-08-18

Read SEC document
July 17, 2023 Filed Jul 20, 2023 01:05 UTC
Grossman FredChief Medical Officer
GrantStock Option (right to buy) · Derivative 74,069 Not disclosed Strike: $4.25 Not disclosed
Disclosure

SEC source: 0001493152-23-024969 · ownership.xml · derivative · entry 1

Grossman Fred · CIK 0001985154 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,069

Underlying: Common Stock, par value $0.0001 per share · 74,069 shares

Expires 2033-07-17

F1 · price: Subject to continuous service, 24,689 of the shares subject to the option will vest on July 17, 2024, and the remaining shares will vest in equal monthly installments over a period of 24 months commencing on August 17, 2024.

F1 · derivative.exercise_date: Subject to continuous service, 24,689 of the shares subject to the option will vest on July 17, 2024, and the remaining shares will vest in equal monthly installments over a period of 24 months commencing on August 17, 2024.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 16:05 UTC
Hepner AdrianChief Medical Officer
GrantStock Option (right to buy) · Derivative 115,000 $0.00 Strike: $3.85 $0.00
Disclosure

SEC source: 0001493152-23-006390 · ownership.xml · derivative · entry 1

Hepner Adrian · CIK 0001637347 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,000

Underlying: Common Stock · 115,000 shares

Expires 2033-02-27

F1 · derivative.exercise_date: Subject to continuous service, the shares subject to the option vest in equal monthly installments over a period of 36 months commencing on March 27, 2023.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 16:05 UTC
SNYDER DAVID SChief Financial Officer
GrantStock Option (right to buy) · Derivative 115,000 $0.00 Strike: $3.85 $0.00
Disclosure

SEC source: 0001493152-23-006389 · ownership.xml · derivative · entry 1

SNYDER DAVID S · CIK 0001398625 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,000

Underlying: Common Stock · 115,000 shares

Expires 2033-02-27

F1 · derivative.exercise_date: Subject to continuous service, the shares subject to the option vest in equal monthly installments over a period of 36 months commencing on March 27, 2023.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 21:05 UTC
Berman HowardDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 165,000 $0.00 Strike: $3.85 $0.00
Disclosure

SEC source: 0001493152-23-006392 · ownership.xml · derivative · entry 1

Berman Howard · CIK 0001952986 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,000

Underlying: Common Stock · 165,000 shares

Expires 2033-02-27

F1 · derivative.exercise_date: Subject to continuous service, the shares subject to the option vest in equal monthly installments over a period of 36 months commencing on March 27, 2023.

Read SEC document
January 03, 2023 Filed Jan 4, 2023 13:30 UTC PurchaseWarrant to Purchase Common Stock · Derivative 5,000 Not disclosed Strike: $7.50 Not disclosed
Disclosure

SEC source: 0001493152-23-000221 · ownership.xml · derivative · entry 2

GOLDSTEIN DOV A MD · CIK 0001120478 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock, par value $0.0001 per share · 5,000 shares

Expires 2025-01-03

F1 · price: Reporting Person purchased 10,000 shares of Common Stock and an accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.